• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Aspire Biopharma Holdings Inc.

    5/30/25 12:15:15 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASBP alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: May 29, 2025 9:00 A.M.
    Form: S-1
    CIK: 0001847345
    Company Name: Aspire Biopharma Holdings, Inc.
    File Number: 333-287240
    Get the next $ASBP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASBP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASBP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASBP
    SEC Filings

    View All

    $ASBP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form PRE 14A filed by Aspire Biopharma Holdings Inc.

    PRE 14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/12/26 5:29:03 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Aspire Biopharma Holdings Inc.

    SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

    2/12/26 1:00:30 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    2/12/26 11:45:27 AM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASBP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

    MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t

    4/16/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

    MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register

    4/15/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance